A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm
Clinical trial NCT00964730 · COMPLETED
Trial details
- NCT number
- NCT00964730
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-01-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.